Functional link between bone morphogenetic proteins and insulin-like peptide 3 signaling in modulating ovarian androgen production

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 15, 2013, Pages

  Glister, Claire ^a   Satchell, Leanne ^a   Bathgate, Ross A D ^b   Wade, John D ^b   Dai, Yanzhenzi ^c   Ivell, Richard ^c   Anand Ivell, Ravinder ^c   Rodgers, Raymond J ^d   Knight, Philip G ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Growth factor; Ovary; Reproduction

Indexed keywords

3 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1; ABIRATERONE; ANDROGEN; ANDROSTENEDIONE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 6; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME P450 17; CYTOCHROME P450 17A1; INSULIN LIKE PEPTIDE 3; MESSENGER RNA; NUCLEAR RECEPTOR SUBFAMILY 5A1; PEPTIDE HORMONE; RELAXIN; UNCLASSIFIED DRUG;

ANDROGEN SYNTHESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HORMONE RELEASE; MICROARRAY ANALYSIS; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FOLDING; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEROIDOGENESIS; THECA CELL; UPREGULATION;

ANDROGENS; ANIMALS; BONE MORPHOGENETIC PROTEINS; CATTLE; CELLS, CULTURED; CLUSTER ANALYSIS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INSULIN; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARY; POLYMERASE CHAIN REACTION; PROTEINS; SIGNAL TRANSDUCTION; STEROID 17-ALPHA-HYDROXYLASE; STEROIDOGENIC FACTOR 1; THECA CELLS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

BOVINAE;

EID: 84876052091     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222216110     Document Type: Article

References (52)

1. Ehrmann DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16(3):322-353.
2. Franks S, McCarthy MI, Hardy K (2006) Development of polycystic ovary syndrome: Involvement of genetic and environmental factors. Int J Androl 29(1):278-285, discussion 286-290.
3. Baird DT, McNeilly AS (1981) Gonadotrophic control of follicular development and function during the oestrous cycle of the ewe. J Reprod Fertil Suppl 30:119-133.
4. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C (1985) The ovarian androgen producing cells: A review of structure/function relationships. EndocrRev 6(3):371-399.
5. Knight PG, Glister C (2006) TGF-beta superfamily members and ovarian follicle development. Reproduction 132(2):191-206.
6. Knight PG, Satchell L, Glister C (2012) Intra-ovarian roles of activins and inhibins. Mol Cell Endocrinol 359(1-2):53-65.
7. Monget P, et al. (2002) Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals. Domest Anim Endocrinol 23(1-2):139-154.
8. Shimasaki S, Moore RK, Otsuka F, Erickson GF (2004) The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25(1):72-101.
9. Magoffin DA, Kurtz KM, Erickson GF (1990) Insulin-like growth factor-I selectively stimulates cholesterol side-chain cleavage expression in ovarian theca-interstitial cells. Mol Endocrinol 4(3):489-496.
10. Spicer LJ, Stewart RE (1996) Interactions among basic fibroblast growth factor, epidermal growth factor, insulin, and insulin-like growth factor-I (IGF-I) on cell numbers and steroidogenesis of bovine thecal cells: Role of IGF-I receptors. Biol Reprod 54(1):255-263.
11. Wrathall JH, Knight PG (1995) Effects of inhibin-related peptides and oestradiol on androstenedione and progesterone secretion by bovine theca cells in vitro. J Endocrinol 145(3):491-500.
12. Young JM, McNeilly AS (2010) Theca: The forgotten cell of the ovarian follicle. Reproduction 140(4):489-504.
13. Glister C, Richards SL, Knight PG (2005) Bone morphogenetic proteins (BMP)-4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: Could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling? Endocrinology 146(4):1883-1892.
14. Glister C, Satchell L, Knight PG (2010) Changes in expression of bone morphogenetic proteins (BMPs), their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: Inhibin can antagonize the suppressive effect of BMPs on thecal androgen production. Reproduction 140(5):699-712.
15. Erickson GF, Shimasaki S (2003) The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol 1:9.
16. Fenwick MA, Mansour YT, Franks S, Hardy K (2011) Identification and regulation of bone morphogenetic protein antagonists associated with preantral follicle development in the ovary. Endocrinology 152(9):3515-3526.
17. Glister C, Kemp CF, Knight PG (2004) Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: Actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127(2):239-254.
18. Glister C, Satchell L, Knight PG (2011) Granulosal and thecal expression of bone morphogenetic protein-and activin-binding protein mRNA transcripts during bovine follicle development and factors modulating their expression in vitro. Reproduction 142(4):581-591.
19. Feng S, et al. (2009) INSL3/RXFP2 signaling in testicular descent. Ann N Y Acad Sci 1160:197-204.
20. Irving-Rodgers HF, Bathgate RA, Ivell R, Domagalski R, Rodgers RJ (2002) Dynamic changes in the expression of relaxin-like factor (INSL3), cholesterol side-chain cleavage cytochrome p450, and 3beta-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia. Biol Reprod 66(4):934-943.
21. Ivell R, Anand-Ivell R (2009) Biology of insulin-like factor 3 in human reproduction. Hum Reprod Update 15(4):463-476.
22. Ivell R, Bathgate RA (2002) Reproductive biology of the relaxin-like factor (RLF/INSL3). Biol Reprod 67(3):699-705.
23. Bao B, Garverick HA (1998) Expression of steroidogenic enzyme and gonadotropin receptor genes in bovine follicles during ovarian follicular waves: A review. J Anim Sci 76(7):1903-1921.
24. Fortune JE (1986) Bovine theca and granulosa cells interact to promote androgen production. Biol Reprod 35(2):292-299.
25. Hillier SG, Whitelaw PF, Smyth CD (1994) Follicular oestrogen synthesis: The 'two-cell, two-gonadotrophin' model revisited. Mol Cell Endocrinol 100(1-2):51-54.
26. Findlay JK (1993) An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 48(1):15-23.
27. Anand-Ivell R, et al. (2011) INSL3 in the ruminant: a powerful indicator of gender-and genetic-specific feto-maternal dialogue. PLoS ONE 6(5):e19821.
28. Satchell L, et al. Ovarian expression of insulin-like peptide 3 (INSL3) and its receptor (RXFP2) during development of bovine antral follicles and corpora lutea and measurement of circulating INSL3 levels during synchronized estrous cycles. Endocrinology, in press.
29. Fatehi AN, et al. (2005) Expression of bone morphogenetic protein2(BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development. Theriogenology 63 (3):872-889.
30. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ (2006) International Union of Pharmacology LVII: Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58(1):7-31.
31. Hanna CB, Yao S, Patta MC, Jensen JT, Wu X (2010) Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques. Reprod Biol Endocrinol 8:150.
32. Hogg K, Etherington SL, Young JM, McNeilly AS, Duncan WC (2010) Inhibitor of differentiation (Id) genes are expressed in the steroidogenic cells of the ovine ovary and are differentially regulated by members of the transforming growth factor-beta family. Endocrinology 151(3):1247-1256.
33. Peng Y, et al. (2004) Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279(31):32941-32949.
34. Nef S, Parada LF (1999) Cryptorchidism in mice mutant for Insl3. Nat Genet 22(3):295-299.
35. Spanel-Borowski K, Schäfer I, Zimmermann S, Engel W, Adham IM (2001) Increase in final stages of follicular atresia and premature decay of corpora lutea in Insl3-deficient mice. Mol Reprod Dev 58(3):281-286.
36. Barrie SE, et al. (1997) Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitors. J Steroid Biochem Mol Biol 60 (5-6):347-351.
37. Yuan FP, et al. (2010) The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice. Reproduction 139(4):759-769.
38. Kawamura K, et al. (2004) Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA 101(19):7323-7328.
39. Bathgate R, et al. (1999) Expression and regulation of relaxin-like factor gene transcripts in the bovine ovary: Differentiation-dependent expression in theca cell cultures. Biol Reprod 61(4):1090-1098.
40. Walther N, Jansen M, Akbary W, Ivell R (2006) Differentiation-specific action of orphan nuclear receptor NR5A1 (SF-1): Transcriptional regulation in luteinizing bovine theca cells. Reprod Biol Endocrinol 4:64.
41. Gambineri A, et al. (2011) Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome. J Endocrinol Invest 34(9):685-691.
42. Weitsman SR, Magoffin DA (1995) Transforming growth factor-α inhibition of luteinizing hormone-stimulated androgen production by ovarian theca-interstitial cells: Mechanism of action. Endocrine 3(6):415-420.
43. Zachow RJ, Tash JS, Terranova PF (1993) Tumor necrosis factor-alpha attenuation of luteinizing hormone-stimulated androstenedione production by ovarian thecainterstitial cells: Inhibition at loci within the adenosine 3', 5'-monophosphatedependent signaling pathway. Endocrinology 133(5):2269-2276.
44. Zimmermann S, et al. (1999) Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 13(5):681-691.
45. Ivell R, Hartung S, Anand-Ivell R (2005) Insulin-like factor 3: Where are we now? Ann N Y Acad Sci 1041:486-496.
46. Gambineri A, et al. (2007) Insulin-like factor 3: A new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. J Clin Endocrinol Metab 92(6):2066-2073.
47. Baptiste CG, Battista MC, Trottier A, Baillargeon JP (2010) Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 122(1-3):42-52.
48. Nisenblat V, Norman RJ (2009) Androgens and polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes 16(3):224-231.
49. Webber LJ, et al. (2003) Formation and early development of follicles in the polycystic ovary. Lancet 362(9389):1017-1021.
50. Shabanpoor F, et al. (2008) Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions. Bioconjug Chem 19(7):1456-1463.
51. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25 (4):402-408.
52. Bleach EC, Glencross RG, Feist SA, Groome NP, Knight PG (2001) Plasma inhibin A in heifers: Relationship with follicle dynamics, gonadotropins, and steroids during the estrous cycle and after treatment with bovine follicular fluid. Biol Reprod 64(3):743-752.